China has granted commercial approval for a brain implant designed to help people with paralysis regain limited hand movement, marking the first time a brain-computer interface (BCI) device of this kind has been authorised for real-world use. The system was developed by Chinese company Neuracle Medical Technology and represents a significant step toward bringing BCI technologies from research labs into clinical practice.
Brain-computer interfaces work by connecting the human nervous system with digital systems capable of interpreting neural signals. By translating brain activity into commands, BCIs allow users to control devices directly through thought. In the case of Neuracle’s system, brain signals linked to the intention to move the hand are detected and processed by software, which then sends commands to a robotic glove worn by the patient.
The glove uses air-powered mechanics to open and close the hand, allowing patients to grasp objects even when spinal cord injuries prevent the brain’s signals from reaching the arms and hands. The technology is primarily designed for people with severe cervical spinal cord injuries who retain some movement in their upper arms but cannot grip objects with their hands.
Eligibility for the device is limited to adults between 18 and 60 who have lived with paralysis for more than a year and whose condition has remained stable for at least six months. This ensures the system is used in patients whose neurological condition is unlikely to change rapidly.
China has been accelerating investment in brain-computer interface technology in recent years, positioning it as a strategic industry for future economic growth. Government planners have included BCI development in national innovation priorities, highlighting the technology’s potential in healthcare, robotics, and human-machine interaction.
The approval comes amid a global race to commercialize neural interface technologies. In 2025, another Chinese company, Shanghai NeuroXess, demonstrated a similar system when a 28-year-old patient with long-term paralysis was able to control digital devices with his thoughts just days after receiving an implant.
Meanwhile, companies in the United States are pushing forward with their own BCI programs. Elon Musk recently stated that his company Neuralink, which began human trials in 2024, plans to start high-volume production of its brain implants in 2026. Neuralink reported that 12 patients with severe paralysis have already received its implants and are using them to control computers and other devices directly through brain signals.
Together, these developments suggest that brain-computer interfaces are moving rapidly from experimental technology toward practical tools that could reshape rehabilitation, assistive technology, and human-computer interaction in the coming decade.
We have helped 20+ companies in industries like Finance, Transportation, Health, Tourism, Events, Education, Sports.
